Week 6 Discussion Response- Healthcare Finance
Week 6 Discussion Response
Healthcare Finance
Colleague 1- Kimberly Simon
Hospital price transparency has become a major policy issue because consumers, employers, and insurers increasingly want to understand what healthcare services actually cost. In the scenario, the hospital faces pressure after media reports identified it as one of the most expensive hospitals in the state. Greater transparency can benefit both the hospital and consumers while also improving economic efficiency by reducing information asymmetry and encouraging value-based competition.
Advantages of Transparency for Hospitals and Consumers
For consumers, transparency provides better information about the expected cost of care before services are delivered. House et al. (2020) argued that consumers often struggle to compare healthcare prices because pricing information is fragmented and difficult to interpret. When hospitals publish clear and accessible pricing data, patients can make more informed decisions about where to seek care, compare alternatives, and better anticipate out-of-pocket expenses. This is particularly important for elective procedures and outpatient services where patients may have the opportunity to shop among providers.
Transparency also benefits employers and other healthcare purchasers. Laffer et al. (2022) found that employers can use price transparency data to negotiate more favorable contracts, design lower-cost provider networks, and steer employees toward high-value providers. As a result, transparency may contribute to lower healthcare spending and slower premium growth for employer-sponsored insurance plans.
Hospitals can benefit from transparency as well. Although public disclosure of high prices may initially create reputational concerns, transparent organizations may build greater trust with patients, employers, and regulators. Transparency can also encourage hospitals to examine their own cost structures and identify opportunities for operational improvement. Getzen and Kobernick (2022) explained that healthcare markets often suffer from limited consumer information, making it difficult for market forces to promote efficiency. By increasing price visibility, hospitals may be encouraged to compete on both cost and quality rather than relying primarily on market power.
How Transparency Improves Economic Efficiency
Hospital cost transparency can improve economic efficiency by reducing information asymmetry between providers and consumers. In traditional healthcare markets, patients often do not know the price of services until after care is delivered, limiting their ability to make cost-conscious decisions. Glied (2021) noted that transparency has the potential to improve market functioning by enabling consumers and purchasers to compare prices across providers. When buyers have better information, providers face stronger incentives to justify high prices through superior quality or reduce prices to remain competitive.
Transparency can also support the transition from volume-based care to value-based care. Under value-based models, providers are rewarded for achieving better outcomes at lower cost. Public reporting of prices and quality metrics allows purchasers to evaluate whether higher-priced hospitals actually deliver better value. Getzen and Kobernick (2022) emphasized that future healthcare systems will increasingly focus on “value for money,” making both cost and quality transparency essential components of efficient healthcare markets.
Recommendations for Regulation and Policy
I would recommend three policy strategies to improve hospital cost comparisons:
· Standardized price reporting requirements
Hospitals should be required to publish machine-readable files and consumer-friendly estimates for common services using standardized definitions. The federal Hospital Price Transparency Rule has improved access to pricing data, but compliance remains inconsistent. Hut (2022) reported that many hospitals have struggled to meet transparency requirements, creating challenges for consumers attempting to compare prices.
· Bundled episode-of-care pricing
Regulators should encourage hospitals to report the total expected cost of a complete episode of care rather than individual line-item charges. Bundled pricing provides consumers with a more accurate estimate of what they are likely to pay for procedures such as joint replacements or maternity care.
· Integration of Price and Quality Data
Price information should be presented alongside quality measures such as readmission rates, infection rates, patient satisfaction scores, and mortality outcomes. Comparing cost alone may encourage consumers to choose the cheapest provider rather than the highest-value provider.
Defending the Recommendations
These recommendations are supported by both economic theory and recent policy research. Standardized reporting reduces information barriers and improves market competition. Bundled pricing aligns with value-based reimbursement by focusing on the total cost of care rather than individual services. Integrating quality data prevents a race to the lowest price and encourages hospitals to compete on value. Strong enforcement ensures that transparency regulations achieve their intended purpose, while public comparison tools make the information accessible to consumers and employers.
Research on healthcare reform also suggests that expanding access to care without addressing price variation may not fully control healthcare spending. De (2021) found that insurance expansion improved healthcare access, but controlling costs remains an ongoing challenge. Similarly, Mazurenko et al. (2018) concluded that Medicaid expansion increased access to care, highlighting the need for complementary policies that address healthcare pricing and efficiency.
Conclusion
Greater hospital price transparency offers important advantages for consumers, employers, and hospitals. Consumers gain the ability to compare costs and anticipate expenses, while hospitals can strengthen trust and identify opportunities for operational improvement. Transparency also improves economic efficiency by reducing information asymmetry and supporting value-based competition. To maximize these benefits, policymakers should require standardized price reporting, encourage bundled episode pricing, integrate quality metrics with cost data, strengthen enforcement of transparency regulations, and develop accessible comparison tools. These policies would help purchasers evaluate hospital value more effectively and encourage healthcare organizations to compete on both quality and affordability.
References
De, P. K. (2021). Impacts of insurance expansion on health cost, health access, and health behaviors: Evidence from the Medicaid expansion in the US. International Journal of Health Economics and Management, 21(4), 495-510.
Getzen, T. E., & Kobernick, M. S. (2022). Health economics & financing (6th ed.). Wiley.
Glied, S. (2021). Price transparency-Promise and peril. JAMA, 325(15), 1496-1497.
House, M. E., Hunt, S. D., & Umeh, A. (2020). Improving price transparency for consumer health care services. Journal of Business & Behavioral Sciences, 32(2), 126-142.
Hut, N. (2022). When it comes to price transparency regulations, questions abound. HFM (Healthcare Financial Management), 76(8), 34-38.
Laffer, A. B., Horn, L. V., & Fisher, C. A. (2022). Employers can revolutionize American healthcare and accelerate economic growth by embracing price transparency. The Independent Review, 27(1), 5-22.
Mazurenko, O., Balio, C. P., Agarwal, R., Carroll, A. E., & Menachemi, N. (2018). The etfects of Medicaid expansion under the ACA: A systematic review. Health Affairs, 37(6), 944-950.
Colleague 2- Victoria Omiti
Regulation, transparency and economic efficiency in hospital markets
Hospital price transparency has become a critical lever for restoring trust and improving economic efficiency; especially in markets publicly identified as highcost. For consumers and employers, transparent pricing reduces information asymmetry, lowers search costs and supports more informed decisionmaking. Research shows that when patients can compare payerspecific negotiated rates and outofpocket estimates, they are better positioned to choose highvalue care (House et al., 2020). Employers also use transparent data to design reference pricing and steerage strategies, which can meaningfully reduce spending without compromising quality (Laffer et al., 2022).
In the scenario (a highprice local hospital market under media scrutiny) is exactly where leadership either doubles down on opacity or uses regulationdriven transparency as a catalyst for redesigning value. Framing transparency as a strategic asset rather than a compliance burden is central to reclaiming trust with patients, employers and purchasers while improving economic efficiency.
Advantages of transparency for hospitals and consumers
Benefits for consumers and employers
· Informed choice and financial protection. Hospital price transparency gives patients and purchasers visibility into negotiated rates, discounted cash prices and expected outofpocket costs before care is delivered (Centers for Medicare & Medicaid Services [CMS], 2026). This supports budgeting and allows employers to steer employees toward highervalue providers.
· Reduced search costs and perceived power imbalance. Historically, patients have faced high search costs and asymmetric information; core drivers of market failure in health care (Getzen & Kobernick, 2022). Transparent, consumerfriendly tools for “shoppable services” (e.g., imaging, elective procedures) lower these search costs and rebalance power between patients and institutions (Gondi et al., 2021; House et al., 2020).
· Quality–price alignment. When price data are paired with quality and safety indicators, consumers can distinguish between lowprice/lowquality and lowprice/highquality options, reinforcing valuebased purchasing rather than simple costcutting (Glied, 2021).
Benefits for hospitals
· Strategic positioning and employer partnerships. In a market publicly labeled “highest in the state,” a hospital that moves first on meaningful transparency can reposition itself as a trustworthy, datadriven partner. Employers increasingly use transparent price data to design reference pricing, centersofexcellence networks and directtoemployer contracts (Laffer et al., 2022).
· Internal cost discipline and service line optimization. Building the infrastructure to comply with the Hospital Price Transparency rule forces hospitals to map costs, contracts and charge structures at a granular level. This often reveals crosssubsidies, outlier prices and lowmargin service lines, enabling more deliberate portfolio management and cost containment (Getzen & Kobernick, 2022; Jiang et al., 2023).
· Reputational capital and regulatory risk mitigation. CMS has progressively increased civil monetary penalties for noncompliance; up to $5,500 per day for larger hospitals, or more than $2 million annually (CMS, 2021). Proactive compliance avoids penalties and negative media coverage while signaling ethical stewardship of community resources.
From a leadership standpoint, transparency becomes a vehicle for rebuilding psychological safety with patients and staff: “We are willing to show our prices, explain them and improve them.”
How hospital cost transparency can improve economic efficiency
In economic terms, transparency addresses classic market failures: information asymmetry, moral hazard and weak price signals.
Correcting information asymmetry
In the competitive market model, prices convey information about scarcity and value. In health care, patients rarely see prices ex ante and insurers negotiate opaque, highly variable rates. Studies of early hospital price transparency data show wide dispersion in commercial prices for the same procedure, with interquartile ranges of 65–82% of median prices across hospitals (Jiang et al., 2023). Making these differences visible allows:
· Purchasers to redirect volume toward efficient providers, increasing price elasticity of demand for shoppable services.
· Insurers to renegotiate contracts using observed benchmarks rather than “black box” rates.
Over time, this can compress unjustified price variation and move the market closer to allocative efficiency.
Incentive realignment and cost containment
Transparency also interacts with valuebased payment:
· Bundled payments and episodebased pricing require clear cost structures to ensure that payment levels reflect realistic resource use (Getzen & Kobernick, 2022).
· Public reporting of prices and quality can support tiered networks and reference pricing, where payers set a maximum contribution and patients pay the difference if they choose higherpriced providers (House et al., 2020).
When employers and health plans use transparent data to design benefit structures, hospitals face stronger incentives to reduce avoidable costs (e.g., length of stay, complications, readmissions) to remain competitive.
From an administrative perspective, transparency is an investment decision. Even with more conservative assumptions, the financial case is positive, before accounting for hardertoquantify benefits such as trust, staff engagement, and reduced media and legal risk.
Current regulatory landscape and evidence (last five years)
Federal hospital price transparency rule
· CMS Hospital Price Transparency Final Rule (effective 2021): Requires hospitals to post machinereadable files with standard charges (including payerspecific negotiated rates and discounted cash prices) and a consumerfriendly display for at least 300 shoppable services.
· Enforcement escalation (2022 onward): CMS substantially increased penalties for noncompliance and now publishes enforcement actions, creating reputational and financial pressure (CMS, 2021, 2026).
Early evaluations show:
· Low but improving compliance. In early 2021, only about onethird of a random sample of hospitals fully complied with key elements of the rule (Gondi et al., 2021). Subsequent analyses through 2022–2023 show gradual improvement but persistent gaps, especially in payerspecific negotiated rates (Jiang et al., 2023).
· Substantial price variation. Even within the same hospital, negotiated rates for the same service can vary severalfold across payers, underscoring the potential for purchasers to use transparency to push for rationalization (Jiang et al., 2023).
Glied (2021) characterizes transparency as both “promise and peril”: promise in enabling more rational purchasing and competition, peril if data are incomplete, confusing, or used by dominant systems to tacitly coordinate higher prices.
Complementary transparency and consumer tools
· No Surprises Act (2022) and related regulations require goodfaith estimates and limit surprise billing, reinforcing the norm that patients should know costs in advance.
· Employerdriven initiatives. Employers and coalitions increasingly use transparent data to design benefit tiers, reference pricing and direct contracting (Laffer et al., 2022).
House et al. (2020) emphasize that transparency must be paired with usability (plain language, clear outofpocket estimates and integration into consumer decision points) to meaningfully influence behavior.
Policy recommendations to compare hospitals based on costs
The leadership voice can frame policy not as something done to the organization, but as a framework the hospital helps shape. The following recommendations integrate federal rules, local policy levers and internal governance.
1. Standardized, audited cost and price reporting
Recommendation: Adopt and advocate standardized reporting of:
· Payerspecific negotiated rates, discounted cash prices and gross charges for a defined set of common inpatient and outpatient services.
· Episodebased prices for highvolume conditions (e.g., joint replacement, heart failure).
Policy mechanism:
· At the federal level, support CMS efforts to refine data dictionaries and standard formats for machinereadable files and to publicly benchmark hospitals on completeness and accuracy.
· At the state or regional level, support an allpayer claims database (APCD) that aggregates claims across payers and enables standardized cost comparisons.
Defense: Standardization reduces “noise” and gaming, enabling applestoapples comparisons across hospitals and payers. From an administrative perspective, it also simplifies internal analytics and contract modeling.
2. Public value dashboards linking cost, quality and equity
Recommendation: Move beyond raw prices to value dashboards that display:
· Riskadjusted episode costs.
· Key quality outcomes (e.g., readmissions, complications, mortality).
· Patientreported experience and access metrics.
· Equity indicators (e.g., disparities in outcomes by race, payer or neighborhood).
Policy mechanism:
· Encourage state health departments or regional collaboratives to publish comparative dashboards using APCD and hospitalreported data.
· Tie participation to eligibility for certain state grants or valuebased payment programs.
Defense: Cost transparency without quality context risks steering patients to lowprice, lowquality care. Value dashboards align with valuebased care principles and support more efficient resource allocation (Getzen & Kobernick, 2022; Glied, 2021).
3. Employeraligned transparency and benefit design
Recommendation: Partner with local employers and purchasers to:
· Codesign reference pricing for selected shoppable services, using transparent data to set a maximum plan contribution.
· Develop centersofexcellence arrangements where the hospital offers bundled prices and quality guarantees.
Policy mechanism:
· Encourage federal and state guidance that clarifies how employers can use price transparency data in benefit design while complying with ERISA and antitrust law.
· Support incentives (e.g., tax credits or grants) for employers who implement valuebased benefit designs using transparent data (Laffer et al., 2022).
Defense: Employers are powerful demandside actors. When they use transparent data to steer volume, hospitals have strong incentives to reduce unwarranted price variation and improve efficiency.
4. Strengthened enforcement with technical assistance
Recommendation: Support a graduated enforcement model that combines:
· Clear, escalating penalties for noncompliance with transparency rules.
· Technical assistance and standardized tools (e.g., CMS data dictionaries, opensource templates) to reduce implementation burden.
Defense: Evidence shows that low penalties and ambiguous expectations contributed to early noncompliance (Gondi et al., 2021; Hut, 2022). A balanced approach protects compliant hospitals from being undercut by opaque competitors while recognizing resource constraints, especially for smaller facilities.
Health insurance expansion, adverse selection and economic implications
Although the immediate brief is price transparency, insurance expansion and adverse selection shape the broader economic environment in which transparency operates.
Adverse selection and the role of expansion
In an unregulated market, individuals with higher expected health costs are more likely to purchase comprehensive coverage, driving up premiums and potentially destabilizing risk pools; classic adverse selection (Getzen & Kobernick, 2022). Health insurance expansion under the Affordable Care Act (ACA), particularly Medicaid expansion, mitigates this by:
· Broadening the risk pool to include healthier, previously uninsured individuals.
· Reducing uncompensated care and cost shifting from uninsured patients to commercial payers.
Mazurenko et al. (2018) found that Medicaid expansion was associated with improved access, reduced uncompensated care and better financial performance for hospitals. De (2021) further showed that expansion improved access and some health behaviors, with nuanced effects on costs.
Economic implications for hospitals and payers
· For hospitals: Expansion reduces bad debt and charity care, stabilizes revenue and can support investments in transparency infrastructure and valuebased care.
· For payers and employers: A more stable insurance market with less adverse selection can moderate premium growth, making it easier to design benefit structures that leverage transparent prices.
In combination, insurance expansion and price transparency address different facets of market failure: expansion improves risk pooling and access; transparency improves price signals and allocative efficiency.
Practical implications for healthcare leaders in the scenario
In a market labeled as “highest priced,” the leadership stance can be:
1. Own the narrative: Publicly commit to exceeding federal transparency requirements and to publishing a value dashboard that integrates cost, quality and equity.
2. Build internal cost literacy: Use the transparency project to train clinical and operational leaders on cost drivers, variation and episodebased performance.
3. Codesign with patients and employers: Involve patient advisors and employer coalitions in designing consumerfacing tools and in selecting priority services for bundled pricing.
4. Measure and communicate ROI: Track avoided penalties, changes in payer mix, shifts in employer contracts and reductions in bad debt to demonstrate that transparency is not just a regulatory checkbox but a financially sound, patientcentered strategy.
This approach aligns with valuebased care, strengthens community trust and positions the hospital as a partner in regional cost containment rather than a target of it.
References
Centers for Medicare & Medicaid Services. (2021). CMS OPPS/ASC final rule increases price transparency, patient safety and access to quality care [Press release].
Centers for Medicare & Medicaid Services. (2026). Hospital price transparency.
De, P. K. (2021). Impacts of insurance expansion on health cost, health access, and health behaviors: Evidence from the Medicaid expansion in the US. International Journal of Health Economics and Management, 21(4), 495–510. https://doi.org/10.1007/s10754-021-09306-5
Getzen, T. E., & Kobernick, M. S. (2022). Health economics & financing (6th ed.). Wiley.
Glied, S. (2021). Price transparency—Promise and peril. JAMA, 325(15), 1496–1497. https://doi.org/10.1001/jama.2021.4640
Gondi, S., Beckman, A. L., Ofoje, A. A., Hinkes, P., & McWilliams, J. M. (2021). Early hospital compliance with federal requirements for price transparency. JAMA Internal Medicine, 181(10), 1396–1397. https://doi.org/10.1001/jamainternmed.2021.2531
House, M. E., Hunt, S. D., & Umeh, A. (2020). Improving price transparency for consumer health care services. Journal of Business & Behavioral Sciences, 32(2), 126–142.
Hut, N. (2022). When it comes to price transparency regulations, questions abound. HFM (Healthcare Financial Management), 76(8), 34–38.
Jiang, J. X., Krishnan, R., & Bai, G. (2023). Price transparency in hospitals—Current research and future directions. JAMA Network Open, 6(1), e2250920.
Laffer, A. B., Horn, L. V., & Fisher, C. A. (2022). Employers can revolutionize American healthcare and accelerate economic growth by embracing price transparency. The Independent Review, 27(1), 5–22.
Mazurenko, O., Balio, C. P., Agarwal, R., Carroll, A. E., & Menachemi, N. (2018). The effects of Medicaid expansion under the ACA: A systematic review. Health Affairs, 37(6), 944–950. https://doi.org/10.1377/hlthaff.2017.1491
· Reply to post from Victoria Aseka Omiti Reply
· Mark as Unread Mark as Unread